- Home
- ATAI vs NVX Comparison
ATAI vs NVX Comparison
Compare ATAI & NVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATAI
- NVX
- Stock Information
- Founded
- ATAI 2018
- NVX 2012
- Country
- ATAI Germany
- NVX Australia
- Employees
- ATAI N/A
- NVX N/A
- Industry
- ATAI Biotechnology: Pharmaceutical Preparations
- NVX Industrial Machinery/Components
- Sector
- ATAI Health Care
- NVX Miscellaneous
- Exchange
- ATAI Nasdaq
- NVX Nasdaq
- Market Cap
- ATAI 214.8M
- NVX 254.2M
- IPO Year
- ATAI 2021
- NVX N/A
- Fundamental
- Price
- ATAI $1.24
- NVX $1.66
- Analyst Decision
- ATAI Strong Buy
- NVX Strong Buy
- Analyst Count
- ATAI 4
- NVX 1
- Target Price
- ATAI $9.00
- NVX $4.00
- AVG Volume (30 Days)
- ATAI 1.3M
- NVX 314.2K
- Earning Date
- ATAI 11-13-2024
- NVX 01-01-0001
- Dividend Yield
- ATAI N/A
- NVX N/A
- EPS Growth
- ATAI N/A
- NVX N/A
- EPS
- ATAI N/A
- NVX N/A
- Revenue
- ATAI $331,000.00
- NVX $6,875,112.00
- Revenue This Year
- ATAI $93.15
- NVX $89.31
- Revenue Next Year
- ATAI N/A
- NVX $410.89
- P/E Ratio
- ATAI N/A
- NVX N/A
- Revenue Growth
- ATAI N/A
- NVX 19.05
- 52 Week Low
- ATAI $1.03
- NVX $1.40
- 52 Week High
- ATAI $2.85
- NVX $3.10
- Technical
- Relative Strength Index (RSI)
- ATAI 33.95
- NVX 40.10
- Support Level
- ATAI $1.15
- NVX $1.50
- Resistance Level
- ATAI $1.69
- NVX $1.88
- Average True Range (ATR)
- ATAI 0.11
- NVX 0.11
- MACD
- ATAI -0.06
- NVX -0.02
- Stochastic Oscillator
- ATAI 3.69
- NVX 21.28
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.
About NVX NOVONIX Limited American Depository Shares
NOVONIX Ltd operates in the lithium-ion battery industry. The company has three operating segments namely Graphite Exploration and Mining, Battery Technology, and NOVONIX Anode Materials. Graphite Exploration and Mining segment is engaged in the exploration and development of high-grade flake graphite deposits. The NOVONIX Anode Materials segment develops and manufactures battery anode materials. The Battery Technology segment develops battery cell testing equipment and carries out research and development in battery development. The Battery Technology segment generates maximum revenue for the company.